AI Article Synopsis
- Small-cell lung cancer (SCLC) makes up about 15% of lung cancer cases and is known for its quick tumor growth, early spread, and strong response to chemotherapy.
- Standard treatment involves platinum-based chemotherapy, thoracic radiotherapy, and preventative cranial irradiation, though second-line chemotherapy offers limited benefits.
- Ongoing research is focused on the biology of SCLC, identifying new therapeutic targets, and the role of circulating tumor cells in understanding cancer mechanisms and developing new treatments.
Article Abstract
Introduction Or Background: Small-cell lung cancer (SCLC) represents ~15% of all cases of lung cancer and is characterized by a rapid tumour doubling time, early onset disease dissemination and high sensitivity to chemotherapy.
Sources Of Data: We searched MEDLINE and OVID databases for articles in English published from January 1980 to February 2015.
Areas Of Agreement: Platinum-based chemotherapy, thoracic radiotherapy and prophylactic cranial irradiation are standard of care. Benefit from second-line chemotherapy is limited.
Areas Of Controversy: The role of platinum/irinotecan chemotherapy in the Western population and the role of maintenance therapies remain to be established.
Growing Points: Knowledge of the biology of SCLC has expanded exponentially and many potential therapeutic targets have been identified.
Areas Timely For Developing Research: The use of circulating tumour cells can help investigating molecular alterations occurring within tumour cells, understanding drug resistance mechanisms and evaluating new treatments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/bmb/ldw022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immunotherapy-extended survival in patients with recurrent pulmonary pleomorphic carcinoma following surgery.
Eur J Surg Oncol
December 2024
Department of Surgery, Tokyo Medical University, Japan.
Objective: Pulmonary pleomorphic carcinoma is a relatively rare and aggressive subtype of non-small cell lung cancer (NSCLC), with a poor prognosis and early recurrence, and is resistant to conventional therapies. This study investigated the efficacy of immune checkpoint inhibitors (ICIs) in improving the survival outcomes of patients with pulmonary pleomorphic carcinoma with postoperative recurrence.
Methods: We conducted a retrospective analysis of 71 patients with pulmonary pleomorphic carcinoma who underwent pulmonary resection at Tokyo Medical University Hospital between 2008 and 2022.
Research Hotspots of Interferon Gamma in the Treatment of Lung Cancer: A Bibliometric Analysis Based on CiteSpace.
J Interferon Cytokine Res
January 2025
Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Interferon-gamma (IFN-γ) is an important cytokine associated with antitumor immunity and has been implicated in the pathogenesis and progression of lung cancer. Nevertheless, no bibliometric analyses have been published in this field to date, and thus we aim to address this gap in knowledge. A search of the Web of Science (WOS) for literature related to the treatment of lung cancer with IFN-γ was conducted from 2002 to 2024.
View Article and Find Full Text PDFImmune checkpoint inhibitors plus taxane-based chemotherapy for patients with advanced/metastatic NSCLC: a systematic review and meta-analysis across different PD-L1 expression levels.
Expert Rev Anticancer Ther
January 2025
Department of Microbiology, Pathology and Forensic Medicine, Faculty of Medicine, The Hashemite University, Zarqa, Jordan.
Background: Immune checkpoint inhibitors (ICIs) are currently the primary approach for managing NSCLC. However, numerous combination therapies are currently under investigation. Our goal is to investigate the overall efficacy and safety of ICIs and taxane-based chemotherapy.
View Article and Find Full Text PDFAssessing the influence of the modifiable areal unit problem on Bayesian disease mapping in Queensland, Australia.
PLoS One
January 2025
QUT Centre for Data Science, Queensland University of Technology, Brisbane, Queensland, Australia.
Background: Spatial data are often aggregated by area to protect the confidentiality of individuals and aid the calculation of pertinent risks and rates. However, the analysis of spatially aggregated data is susceptible to the modifiable areal unit problem (MAUP), which arises when inference varies with boundary or aggregation changes. While the impact of the MAUP has been examined previously, typically these studies have focused on well-populated areas.
View Article and Find Full Text PDFOral Microalgae-Based Biosystem to Enhance Irreversible Electroporation Immunotherapy in Hepatocellular Carcinoma.
Adv Sci (Weinh)
January 2025
Department of Surgery, Center for Cancer Medicine, the Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China.
Irreversible electroporation (IRE) is a novel local tumor ablation technique that can potentially stimulate immune responses. However, IRE alone cannot effectively activate the immune system or prevent distant metastases. Therefore, this study utilized the biocompatibility of Chlorella vulgaris (C.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!